Program
Saturday, February 1
SUNDAY, FEBRUARY 2
- Plenary Session 1: Twenty-Five Years Later: New Concepts in Cancer Epigenetic
- Plenary Session 2: Interpreting Methylation Signals
- Plenary Session 3: DNA Methylation in a Chromatin Context
- Lighting Talks A
MONDAY, FEBRUARY 3
- Plenary Session 4: Role of DNA Methylation and Hydroxymethylation in Immune Cell Function
- Plenary Session 5: Clonal Hematopoiesis
- Plenary Session 6: Normal and Abnormal Methylation Patterns and Detection
- Lighting Talks B
TUESDAY, FEBRUARY 4
- Rising Star Keynote
- Plenary Session 7: New DNMTis, Combinations, and Responses
- Closing Remarks and Departure
Saturday, February 1
Registration
4-8 P.M.
Welcome and Keynote Lectures
6:30-8:10 P.M.
- Welcome and Opening Remarks
Margaret A. Goodell, Baylor College of Medicine, Houston, Texas - Introduction of Keynote Speaker
Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland - The role of DNMT3A in myeloid malignancies
Timothy J. Ley, Washington University School of Medicine, St. Louis, Missouri - Introduction of Keynote Speaker
Peter A. Jones, Van Andel Institute, Grand Rapids, Michigan - Origins of DNA methylation alterations in cancer
Peter W. Laird, Van Andel Institute, Grand Rapids, Michigan
OPENING RECEPTION
8:10-10 P.M.
SUNDAY, FEBRUARY 2
CONTINENTAL BREAKFAST
7-8 a.m.
PLENARY SESSION 1: Twenty-Five Years Later: New Concepts in Cancer Epigenetics
8-9:50 A.M.
- Susan J. Clark, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
- Jean-Pierre J. Issa, Coriell Institute for Medical Research, Camden, New Jersey
- Hariharan Easwaran, Johns Hopkins University School of Medicine, Baltimore, Maryland
BREAK
9:50-10:10 A.M.
PLENARY SESSION 2: : Interpreting Methylation Signals
- Dirk Schuebeler, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
- Victor Corces, Emory University School of Medicine, Atlanta, Georgia
- Manel Esteller, Josep Carreras Leukemia Research Institute, Barcelona, Spain
LUNCH ON OWN / Free Time
12:20-4 P.M.
Plenary Session 3: DNA Methylation in a Chromatin Context
4-6 P.M.
- Xiaodong Cheng, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Peter A. Jones, Van Andel Institute, Grand Rapids, Michigan
- Margaret A. Goodell, Baylor College of Medicine, Houston, Texas
Lightning Talk A
6-6:15 p.m.
Poster A and Reception
6:15-8:45 p.m.
MONDAY, FEBRUARY 3
CONTINENTAL BREAKFAST
7-8 a.m.
Plenary Session 4: Role of DNA Methylation and Hydroxymethylation in Immune Cell Function
8-9:50 A.M.
- Yun Nancy Huang, Texas A&M University, Houston, Texas
- Benjamin A. Youngblood, St. Jude Children’s Research Hospital, Memphis, Tennessee
- Anjana Rao, La Jolla Institute for Immunology and University of California at San Diego, La Jolla, California
BREAK
9:50-10:10 A.M.
Plenary Session 5: Clonal Hematopoiesis
10:10 A.M.-12:30 P.M.
Session Chair: Kirsten Grønbaek, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- Kirsten Grønbaek
- Jennifer Trowbridge, The Jackson Laboratory, Bar Harbor, Maine
- Alexander G. Bick, Vanderbilt University Medical Center, Nashville, Tennessee
- Katherine King, Baylor College of Medicine, Houston, Texas
LUNCH ON OWN / Free Time
12:20-4 P.M.
Plenary Session 6: Normal and Abnormal Methylation Patterns and Detection
4:30-6:20 P.M.
Session Chair: Ting Wang, Washington University in St. Louis, St. Louis, Missouri
- Ting Wang
- Tommy Kaplan, The Hebrew University of Jerusalem, Jerusalem, Israel
- Daniel D. De Carvalho, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Lightning Talk b
6:20-6:45 P.m.
Poster b and Reception
6:45-9:15 p.m.
TUESDAY, FEBRUARY 4
CONTINENTAL BREAKFAST
7-8 a.m.
Rising Star Keynote
8-8:45 a.m.
- Introduction of Rising Star Keynote Speaker
Margaret A. Goodell, Baylor College of Medicine, Houston, Texas - Keynote Speaker
Zuzana Tothova, Dana-Farber Cancer Institute, Boston, Massachusetts
BREAK
8:45-9 a.m.
Plenary Session 7: New DNMTis, Combinations, and Responses
9-10:45 A.M.
- Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
- Guillermo Garcia-Manero, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Additional speaker to be announced